226 related articles for article (PubMed ID: 23086794)
1. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.
Steigerwald K; Ballke S; Quee SC; Byrne RA; Vorpahl M; Vogeser M; Kolodgie F; Virmani R; Joner M
EuroIntervention; 2012 Oct; 8(6):752-9. PubMed ID: 23086794
[TBL] [Abstract][Full Text] [Related]
2. Resolute and Xience V polymer-based drug-eluting stents compared in an atherosclerotic rabbit double injury model.
Van Dyck CJ; Hoymans VY; Bult H; Fransen E; Haine S; Bosmans JM; Timmermans JP; Vrints CJ
Catheter Cardiovasc Interv; 2013 Jun; 81(7):E259-68. PubMed ID: 22887820
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents.
Mori H; Cheng Q; Lutter C; Smith S; Guo L; Kutyna M; Torii S; Harari E; Acampado E; Joner M; Kolodgie FD; Virmani R; Finn AV
JACC Cardiovasc Interv; 2017 Dec; 10(23):2375-2387. PubMed ID: 29102583
[TBL] [Abstract][Full Text] [Related]
4. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.
John MC; Wessely R; Kastrati A; Schömig A; Joner M; Uchihashi M; Crimins J; Lajoie S; Kolodgie FD; Gold HK; Virmani R; Finn AV
JACC Cardiovasc Interv; 2008 Oct; 1(5):535-44. PubMed ID: 19463356
[TBL] [Abstract][Full Text] [Related]
5. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
[TBL] [Abstract][Full Text] [Related]
6. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
Nakazawa G; Finn AV; John MC; Kolodgie FD; Virmani R
Am J Cardiol; 2007 Oct; 100(8B):36M-44M. PubMed ID: 17950831
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents.
Yazdani SK; Sheehy A; Nakano M; Nakazawa G; Vorpahl M; Otsuka F; Donn RS; Perkins LE; Simonton CA; Kolodgie FD; Virmani R
J Invasive Cardiol; 2013 Aug; 25(8):383-90. PubMed ID: 23913602
[TBL] [Abstract][Full Text] [Related]
8. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell recovery between comparator polymer-based drug-eluting stents.
Joner M; Nakazawa G; Finn AV; Quee SC; Coleman L; Acampado E; Wilson PS; Skorija K; Cheng Q; Xu X; Gold HK; Kolodgie FD; Virmani R
J Am Coll Cardiol; 2008 Jul; 52(5):333-42. PubMed ID: 18652940
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
13. Vascular responses to a biodegradable polymer (polylactic acid) based biolimus A9-eluting stent in porcine models.
Hagiwara H; Hiraishi Y; Terao H; Hirai T; Sakaoka A; Sasaki M; Murota S; Inoue K; Kimura J
EuroIntervention; 2012 Oct; 8(6):743-51. PubMed ID: 23086793
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus.
Zhao HQ; Nikanorov A; Virmani R; Schwartz LB
J Vasc Surg; 2012 Dec; 56(6):1680-8. PubMed ID: 22841285
[TBL] [Abstract][Full Text] [Related]
15. Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis.
Hoymans VY; VAN Dyck CJ; Haine SE; Frederix G; Fransen E; Timmermans JP; Vrints CJ
J Interv Cardiol; 2014 Aug; 27(4):381-90. PubMed ID: 24815761
[TBL] [Abstract][Full Text] [Related]
16. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
[TBL] [Abstract][Full Text] [Related]
17. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
[TBL] [Abstract][Full Text] [Related]
18. Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study.
Nakamura T; Winsor-Hines D; Yin X; Sushkova N; Chen JP; King SB; Chronos N; Eppihimer M; Huibregtse B; Dawkins KD; Hou D
EuroIntervention; 2012 Aug; 8(4):493-500. PubMed ID: 22917733
[TBL] [Abstract][Full Text] [Related]
19. Experimental evaluation of efficacy and healing response of everolimus-eluting stents in the familial hypercholesterolemic swine model: a comparative study of bioabsorbable versus durable polymer stent platforms.
Tellez A; Seifert PS; Donskoy E; Sushkova N; Pennington DE; Milewski K; Krueger CG; Kaluza GL; Eppihimer MJ; Huibregtse BA; Dawkins KD; Granada JF
Coron Artery Dis; 2014 May; 25(3):198-207. PubMed ID: 24642807
[TBL] [Abstract][Full Text] [Related]
20. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A
Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]